Prevalencia de enfermedades reumatológicas en pacientes con psoriasis atendidos en el Hospital Monte Sinaí en el periodo 2023 al 2025.

Abstract

Introduction: Psoriasis is a chronic inflammatory disease that is not limited to the skin and can affect other systems. Among its associated manifestations, rheumatological involvement stands out due to its impact on patient function and prognosis Objective: To determine the prevalence of rheumatological diseases in patients with psoriasis treated at Monte Sinaí Hospital between 2023 and 2025. Methods: An observational, cross-sectional, and retrospective study was conducted at Monte Sinaí General Hospital during the period 2023–2025. Medical records of patients over 18 years of age diagnosed with psoriasis were reviewed. The information was organized into a database and analyzed using descriptive and inferential statistics, with statistical significance set at p < 0.05. Results: Rheumatological involvement was identified in 74 patients (29.8%). Psoriatic arthritis was the most common (16.5%), followed by spondyloarthritis (4.8%) and rheumatoid arthritis (3.6%). Plaque psoriasis predominated (68.1%). The most common clinical type of psoriasis, accounting for 68.1% of cases, was plaque psoriasis. The prevalence of rheumatological diseases correlated with the severity of psoriasis, with a prevalence of 50.9% among patients with severe disease, a finding that was statistically significant (p < 0.001). Conclusion: Psoriasis coexists significantly with other autoimmune diseases, suggesting the need to strengthen timely detection through routine screening.